Skip to content

Clinical trials

Phase 2/3 COVID-19 trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2/3 Country / region: Argentina Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202010
20218

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Invivyd, Inc.2
ARCA Biopharma, Inc.1
Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran1
Australian National University1
BioNTech SE1
CureVac1
Inmunova S.A.1
Instituto de Cardiología de Corrientes1
Laboratorios Roemmers S.A.I.C.F.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1918
Coronavirus Infections3
RNA Virus Infections2
Virus Diseases2
Coronaviridae Infections1
Inflammation1
Nidovirales Infections1
Respiratory Tract Diseases1
Respiratory Tract Infections1
Severe Acute Respiratory Syndrome1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.